Robert Grant Edwards serves as Executive at Sonoma Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Robert Grant Edwards has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 23, 2020 involved receiving (via award) 2,609 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Apr 23, 2020 | SNOA | $0 | Award | 2,609 | $N/A | Discretionary |
Robert Grant Edwards currently holds 2,609 shares of Sonoma Pharmaceuticals, Inc. (SNOA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Grant Edwards has been a net neutral trader of SNOA stock. They have purchased $0 and sold $0 worth of shares.
Robert Grant Edwards's most recent insider trade was on Apr 23, 2020, when they sold 2,609 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted